SAARBRÜCKEN und HEIDELBERG–(BUSINESS WIRE)–URSAPHARM, eines der führenden europäischen Unternehmen auf dem Gebiet der Augenheilkunde, und Novaliq, ein Unternehmen für pharmazeutische Spezialprodukte in der klinischen Entwicklung mit einer innovativen Drug-Delivery-Plattform mit Schwerpunkt in der Augenheilkunde, meldeten heute gemeinsam die Unterzeichnung der Partnerschaftsvereinbarung sowie den ersten Marktauftritt von EvoTears™ in Europa. Im Rahmen der Vereinbarung erhält URSAPHARM die exkl
The WHO’s ‘World Report on Aging and Health’ advises thinking about expenditures for older adults as ‘investments’ rather than ‘costs’ and calls for a re-examination of outdated stereotypes. Medscape Medical News
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Acacia Research Corporation (NASDAQ: ACTG) announced today that its Labyrinth Optical Technologies LLC subsidiary has entered into a settlement and patent license agreement with Alcatel Lucent USA Inc. The agreem…
The results show that Oraya Therapy is effective in maintaining vision with reduced injections for patients at different stages of their disease—from chronic patients in discontinuous treatment to treatment-naive patients with new diagnosis—and following different treatment pathways.
OULU, Finland–(BUSINESS WIRE)–Optomed Oy, Finland based and the world’s fastest growing retinal company received significant investment from Robert Bosch Venture Capital GmbH (RBVC), Germany. “This investment will be used to accelerate growth across the business, to advance our product development and help us to successfully execute our strategy. It is a big recognition towards both our technology and our team in Finland. We are proud to welcome RBVC as one of our investors. With their suppor
Patterns of compliance with glaucoma therapy established in the first year after new diagnosis changed little over subsequent years, according to a study.Using group-based trajectory modeling (GBTM) over 4 years of follow-up, the retrospective longitud…